Germany Pharmaceutical and Medical Goods Expenditure Share (2024)
Germany's Pharmaceutical and Medical Goods Expenditure Share: 18.2 % of current health expenditure in 2024, +0.1pp YoY.
Germany (2024)
18.2
% of current health expenditure
+0.1pp YoY
YoY Change
+0.1pp
percentage points
Trend
up
Series length
20
years of data
Data
| Year | % of current health expenditure | YoY Change |
|---|---|---|
| 2024 | 18.2 | +0.1pp |
| 2023 | 18.1 | +0.4pp |
| 2022 | 17.7 | -1pp |
| 2021 | 18.7 | +0.3pp |
| 2020 | 18.4 | -0.4pp |
| 2019 | 18.8 | -0.5pp |
| 2018 | 19.3 | -0.1pp |
| 2017 | 19.4 | -0.5pp |
| 2016 | 19.9 | -0.1pp |
| 2015 | 20 | +0.2pp |
| 2014 | 19.8 | +0.3pp |
| 2013 | 19.5 | unchanged |
| 2012 | 19.5 | -0.1pp |
| 2011 | 19.6 | -0.6pp |
| 2010 | 20.2 | -0.2pp |
| 2009 | 20.4 | -0.1pp |
| 2008 | 20.5 | -0.1pp |
| 2007 | 20.6 | +0.4pp |
| 2006 | 20.2 | +0.1pp |
| 2005 | 20.1 | n/a |
About this Dataset
Germany recorded 18.2 % of current health expenditure in 2024. The latest change was +0.1pp. Across 2005–2024 the series ranges from 17.7 % of current health expenditure in 2022 to 20.6 % of current health expenditure in 2007.
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Germany.
Data sourced from Eurostat via SDMX REST API. Values use harmonised methodology intended for cross-country comparison.
Frequently Asked Questions
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Germany. It is published by Eurostat and updated annually.
The most recent observation covers 2024. Eurostat typically publishes this series with a lag of several months after the reference period. The series runs 2005–2024 (20 observations).
The series peaked at 20.6 % of current health expenditure in 2007 and reached its lowest recorded value of 17.7 % of current health expenditure in 2022. The latest reading is 18.2 % of current health expenditure in 2024. The latest change was +0.1pp.